Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Overdose Prevention Centers topic
No spam. Unsubscribe anytime.
Public Health Committee advances overdose prevention center pilot bill after hours of testimony
Summary
The committee approved Senate Bill 1285 to create a four‑site overdose prevention center pilot program, advancing it to the floor for further action. Lawmakers and advocates debated details including funding, regulation, age limits and links to treatment.
The Public Health Committee advanced Senate Bill 1285 on a motion by Senator Anwar, seconded by Representative Jenga, moving the measure to the floor for further consideration.
The bill would permit the Department of Mental Health and Addiction Services (DMHAS) and the Department of Public Health (DPH) to create an overdose prevention center (OPC) pilot in up to four Connecticut municipalities, subject to the approval of the local chief elected official. The legislation authorizes an advisory committee chaired by the DMHAS commissioner, allows DMHAS to accept grants and donations for the pilot, and states that a certificate of need (CON) would not be required to open the pilot sites. The s-language in committee replaces mandatory language with permissive language and clarifies that no state funds are to be used for the pilot.
Committee proponents framed the bill as a public‑health intervention to reduce preventable overdose deaths. Senator Ammar (Senator) said Connecticut’s per‑capita overdose death rate is higher than the national average and recited a multiyear series of annual overdose totals discussed in testimony, arguing the state is “late” to adopt the intervention and describing evidence from other jurisdictions. He cited international experience — “over 200 OPCs around the world” — and research showing reductions in deaths and infectious disease risk following OPC openings. He also referenced studies showing increased entry to treatment after supervised consumption programs, and described federal criminal law (21 U.S.C. § 856, sometimes called the “crack house” provision) as inapplicable, saying the bill is a public‑health measure, not a promotion of illegal activity.
Opponents and skeptical members voiced concerns about federal legal risk, local siting, program operations, and whether OPCs increase engagement in treatment. Representative Claire DiSteitria (Representative) asked for details about facility layout, visibility within facilities, and age restrictions; committee chairs and Senator Ammar said such operational specifics would be set by regulation and by an expert regulatory process informed by examples from Rhode Island and New York. Representative DiSteitria and others pressed for data on how many OPC clients later enter treatment; committee proponents responded that published analyses show increased likelihood of entering rehabilitation (they cited a range of roughly 30–60 percent in some settings) but said Rhode Island’s pilot was too recent to provide long‑term follow‑up data at the time of the hearing.
Representative Kennedy and other members shared personal testimony about family losses to fentanyl and described the vote as emotionally charged. Several members expressed a desire to “save as many lives as possible” while acknowledging differing views on the best strategies.
The bill directs the agencies to report back to the committee and creates an advisory committee to draft regulations on licensing, liability, staff and referral procedures. The bill specifies that no state funds shall be used for construction or operation of the pilot sites, though DMHAS may accept grants, donations and other outside resources for implementation.
The committee discussion repeatedly returned to three practical points: (1) federal legal risk and the committee’s understanding of it; (2) the decision to leave operational specifics to the regulatory process (with referenced models from Rhode Island and New York); and (3) the goal of linking life‑saving supervision to opportunities for treatment and recovery.
The committee recorded roll‑call votes during the meeting and left the vote(s) open later in the afternoon; committee leadership said votes would be held open until 4:30 p.m. for any members joining remotely. The committee approved the measure to be reported to the floor as a JFS to the floor.
A number of advocates and public witnesses were thanked by members for their testimony; several members urged continuing data collection and regulatory detail prior to implementation.
